Lobe Sciences Ltd. (CSE: LOBE) (OTC: GTSIF) Featured in Virtual Coverage of Investor Summit Group’s Q1 Virtual Summit
Lobe Sciences Ltd. (CSE: LOBE) (OTC: GTSIF) is a life sciences company focused on psychedelic medicines. The company, through collaborations with industry leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness. Lobe Sciences seeks to advance clinical development of devices and medicines to treat neurological disorders and…